اليوم السابع
اليوم السابع
Ready to play
Ready to play
The Egyptian Drug Authority has confirmed that all types and formulations of insulin registered and circulating in the Egyptian market are currently available, and there is no decision to halt the import of any kind. It clarified that the supply of certain insulins to government entities is part of policies aimed at rationalizing dependence on imports, especially for products that have sufficient local alternatives in terms of quantity and quality. The authority also reaffirmed that it continues to ensure the availability of insulin, whether locally manufactured or imported, in accordance with the needs of the public sector. Increasing reliance on local manufacturing does not mean flooding the market or banning the import of products; rather, it aims to strengthen local production while maintaining a variety of alternatives, efficiency, and quality. The authority continuously monitors the availability of insulin and its supply chains to ensure they are not interrupted, adhering to regulatory standards, and emphasizing that there is no decision to halt imports or prohibit the circulation of any type of insulin in the Egyptian market.
Notice: This Is an AI-Generated Summary
Comments (0)